At a glance
ClinicalIndex Comparison RecordN/ACompleted· 116 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis
In Brief
An observational study evaluating No Intervention for Aspergillosis. Completed, enrolled 116 participants.
Detailed Summary
The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that over the initial two weeks of anti-fungal therapy, fungal biomarkers from participants with invasive aspergillosis (IA) will be lower for those with a successful clinical outcome compared to those with a failed clinical outcome.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAspergillosis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedMar 2009
Primary CompletionJun 2011
Study CompletionAug 2011
TodayJul 2026
First PostedMar 3, 2009
Enrollment StartMar 1, 2009
Primary CompletionJun 1, 2011
Study CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.3 years ago
Interventions
No Interventionother
Blood samples will be collected for 12 weeks to evaluate levels of fungal biomarkers.